Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?-Reference-Cited by-同舟云学术

Is amiloride a promising cardiovascular medication to persist in the COVID-19 crisis?

Published:2020-10-31 Issue:5 Volume:14 Page:256-258
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Adil Mir S.¹,Narayanan S. Priya¹,Somanath Payaningal R.¹

Affiliation:

1. Clinical and Experimental Therapeutics, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA, USA.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/14/5/14_2020.03070/_pdf

Reference20 articles.

1. 1. Morens DM, Daszak P, Markel H, Taubenberger JK. Pandemic COVID-19 Joins History's Pandemic Legion. mBio. 2020; 11:e00812-20

2. 2. Trifirò G, Crisafulli S, Andò G, Racagni G, Drago F. Should patients receiving ACE inhibitors or angiotensin receptor blockers be switched to other antihypertensive drugs to prevent or improve prognosis of novel coronavirus disease 2019 (COVID-19)? Drug Saf. 2020; 43:507-509.

3. 3. Khulood D, Adil MS, Sultana R, Nimra. Convalescent plasma appears efficacious and safe in COVID-19. Ther Adv Infect Dis. 2020; 7:2049936120957931.

4. 4. Khashkhusha TR, Chan JSK, Harky A. ACE inhibitors and COVID-19: We don't know yet. J Card Surg. 2020; 35:1172-1173.

5. 5. Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence? J Clin Hypertens (Greenwich). 2020; 22:943-948.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitination of angiotensin-converting enzyme 2 contributes to the development of pulmonary arterial hypertension mediated by neural precursor cell–expressed developmentally down-regulated gene 4-Like;Respiratory Research;2024-08-29

2. Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions;International Journal of Molecular Sciences;2024-06-29

3. Drugs for the treatment of postmenopausal symptoms: Hormonal and non-hormonal therapy;Life Sciences;2023-01

4. Competitive cleavage of SARS-CoV-2 spike protein and epithelial sodium channel by plasmin as a potential mechanism for COVID-19 infection;American Journal of Physiology-Lung Cellular and Molecular Physiology;2022-11-01

5. The effect of various compounds on the COVID mechanisms, from chemical to molecular aspects;Biophysical Chemistry;2022-09